PECAM1 and carcinoma: However, evaluation of the association between CD31 positivity and tumor features exhibited no noteworthy correlation among the CD31 positivity and patients’ age, sex, tumor site and size, subtypes of carcinoma, and also presence of lymphovascular invasion using H&E staining (P>0.05) (Table 2).